Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort-Reference-Cited by-同舟云学术

Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort

Published:2015-06-22 Issue:12 Volume:22 Page:1020-1032
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Doyle J. S.¹²³,Deterding K.⁴⁵,Grebely J.⁶,Wedemeyer H.⁴⁵⁷,Sacks-Davis R.¹²,Spelman T.¹,Matthews G.⁶,Rice T. M.⁸,Morris M. D.⁸,McGovern B. H.⁹,Kim A. Y.¹⁰,Bruneau J.¹¹,Lloyd A. R.¹²,Page K.⁸,Manns M. P.⁴⁵⁷,Hellard M. E.¹²³,Dore G. J.⁶,

Affiliation:

1. Centre for Population Health; Burnet Institute; Melbourne Vic. Australia

2. School of Population Health and Preventive Medicine; Monash University; Melbourne Vic. Australia

3. Department of Infectious Diseases; The Alfred Hospital; Melbourne Vic. Australia

4. Hannover Medical School; Hannover Germany

5. Hep-Net Study House: German Network of Competence on Viral Hepatitis; Hannover Germany

6. Kirby Institute; UNSW Australia; Sydney NSW Australia

7. German Centre for Infection Research (DZIF); Hannover-Braunschweig Germany

8. Department of Epidemiology and Biostatistics; University of California San Francisco; San Francisco CA USA

9. Tufts Medical School; Boston MA USA

10. Harvard Medical School; Boston MA USA

11. CRCHUM; Université de Montréal; Montreal QC Canada

12. School of Medical Sciences; UNSW Australia; Sydney NSW Australia

Funder

National Institute on Drug Abuse Award Number

Burnet Institute

Kirby Institute

Australian Government Department of Health and Ageing

German Network of Competence on Viral Hepatitis

German Federal Ministry of Education and Research

Essex Pharma

Meso Scale Diagnostics

Schering-Plough

National Institutes of Health

Fonds de la Recherche du Québec - Santé Research Career

Victorian Operational Infrastructure Support Program

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12429/fullpdf

Reference40 articles.

1. Epidemiology and natural history of HCV infection;Hajarizadeh;Nat Rev Gastroenterol Hepatol,2013

2. Effective treatment of injecting drug users with recently acquired Hepatitis C virus Infection;Dore;Gastroenterology,2010

3. Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial;Deterding;Lancet Infect Dis,2013

4. Treatment of acute HCV infection;Grebely;Nat Rev Gastroenterol Hepatol,2011

5. Current and emerging antiviral treatments for hepatitis C infection;Doyle;Br J Clin Pharmacol,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study;Hepatology;2024-05-20

2. Cohort Profile: The Melbourne Injecting Drug User Cohort Study (SuperMIX);International Journal of Epidemiology;2021-12-28

3. Acute HCV Treatment: What Should We Do in the DAA Era?;Current Hepatology Reports;2019-05-02

4. Role of soluble inflammatory mediators and different immune cell populations in early control of symptomatic acute hepatitis C virus infection;Journal of Viral Hepatitis;2018-12-08

5. Changing the odds: motives for and barriers to reducing HCV-related sexual risk behaviour among HIV-infected MSM previously infected with HCV;BMC Infectious Diseases;2018-12